Plasma hemoglobin (Hb) is elevated in some hematologic disease states, during exposures to certain toxicants, and with the use of some medical devices. Exposure to free Hb can precipitate oxidative reactions within tissues and alter the normal physiological function of critical organ systems. As kidney structures can be highly sensitive to Hb exposures, we evaluated the acute dose dependent renal toxicologic response to purified Hb isolated from RBCs. Male Hartley guinea pigs (n ¼ 5 per group) were dosed with 0.9% saline (2 ml), 15, 75, 150, or 300 mg of purified Hb, infused over a 2-h period. The primary endpoints of this study were to define toxicokinetic parameters after increasing doses of purified Hb, identify clinically recognized and experimental markers of acute kidney injury (AKI), and determine relevant toxicological parameters and potential causes of renal toxicity in this model. Experimental findings demonstrated a dose dependent increase in C max after a 2-h infusion, which correlated with an elevation in serum creatinine, renal Kim-1 mRNA expression and increased urinary Kim-1. Renal NGAL mRNA expression and urinary NGAL excretion were also increased in several groups, but these parameters did not correlate with exposure. Iron increased in the renal cortex as Hb exposure increased and its deposition colocalized with 4-hydroxy-nonenal and 8-Oxo-2-deoxyguanosine immune reactivity, suggesting oxidative stressors may contribute to AKI in animals exposed to Hb. The results presented here suggest that C max may effectively predict the risk of AKI in normal healthy animals exposed to Hb.
Intravascular hemolysis can occur after mechanical, chemical, or thermal injury to circulating red blood cells (RBCs) . The release of hemoglobin (Hb) into the plasma from damaged RBCs results in saturation of haptoglobin (Hp), the putative Hb binding and clearance protein (Andersen et al., 2012) . Hp levels in plasma range from 0.3 to 2 mg/ml, and typically decrease during hemolytic diseases (Muller-Eberhard et al., 1968) . As a result, an imbalance in Hp saturation versus biosynthesis can occur with rapid bursts of intravascular RBC lysis (Noyes and Garby, 1967) . Hb-Hp complexes are cleared after binding to cluster of differentiation 163 sites on macrophages by the spleen and liver (Kristiansen et al., 2001) , while free Hb is either distributed to tissue or cleared via the kidneys and excreted in the urine. Elimination of Hb from the central compartment generally follows a first order process whether Hb is bound to Hp or not (Dale et al., 1972) .
Without the protective mechanisms available within the RBC and following the depletion of plasma Hp, distribution outside of the central compartment greatly enhances the toxicologic potential of Hb. Tissue compartmentalization of free Hb leads to decreased nitric oxide (NO) bioavailability (Schaer et al., iron deposition (Boretti et al., 2009) . Each affects the progression of chronic disease following long term exposures to Hb (Rother et al., 2005) . However, pathophysiology can also occur following acute intravascular RBC lysis and this becomes particularly problematic with concomitant diseases of the cardiovascular system or kidneys (Brain et al., 1962; Qian et al., 2010) . As a consequence, acute kidney injury (AKI) is reported to occur following acute hemolytic disease (Ballarin et al., 2011) and with the short-term use of some medical devices, such as blood pumps, oxygenators, and cannula used in cardio-pulmonary bypass (CPB) (Rosner and Okusa, 2006; Vermeulen Windsant et al., 2010 . The incidence of AKI in CPB can range from 3% to 48% depending on the procedure and is often associated with hemolysis (Abu-Omar and Ratnatunga, 2006; Mehta et al., 2006) .
To study Hb exposure dependent effects, we evaluated if an animal model could be effectively applied to help predict shortterm intravascular Hb exposures that define the risk of AKI. Guinea pigs were studied as a species of interest due to their inability to produce ascorbate, a physiological characteristic shared with humans (Chatterjee, 1973) . Ascorbate is a key small molecule that acts as a plasma and tissue antioxidant and directly impacts Hb oxidation and lipid peroxidation (Chakraborty et al., 1994) . Therefore, human translational aspects of Hb exposure, not seen in other rodent species, are highly relevant to this study using guinea pigs (Buehler et al., 2007) . Guinea pigs also demonstrate enzymatic antioxidant tissue concentrations unique from other rodents (mice and rats) that more closely align with humans (Himeno et al., 1993; Nandi et al., 1997) . Finally, guinea pigs have negligible Hp levels (Boretti et al., 2009) , allowing us to study the acute effects of Hb absent Hp binding. The kidneys were chosen as they represent an important route of Hb elimination. Furthermore, Hb induced renal injury is reportedly caused by the oxidation of ferrous (Fe 2þ ) Hb to ferric (Fe3þ) Hb Zager and Gamelin, 1989) . Therefore, purified Hb obtained from human RBCs was studied to focus only on the toxicological response caused by Hb exposure and to avoid the potential contributions of RBC components from crude hemolysate. We hypothesized that Hb plasma levels and exposure to the kidneys over a 2-h period of Hb infusion, used here to mimic typical acute disease and durations of on-pump CPB surgical procedures, could help define Hb exposure limits. Exposure is defined here both as AUC 0-t-last and C max concentrations following Hb infusion. Both values were correlated with plasma creatinine, the currently accepted biomarker used to define AKI in humans (Kellum et al., 2002 Lameire et al., 2013) , and further correlated with experimental renal damage biomarkers such as Kim-1 renal mRNA expression and Kim-1 urinary excretion. Renal pathology, iron deposition, and markers of oxidative stress (4-hydroxy-nonenal [4-HNE] and 8-Oxo-2-deoxyguanosine [8-OHdG]) were studied to help understand potential causes of renal injury in this model. Finally, the translational aspects of the guinea pig model were compared with humans by evaluating exposure to free Hb in plasma following CPB-associated hemolysis derived from the AUC of plasma Hb versus time curve (Vermeulen Windsant et al., 2010) , or alternatively from Hb C max (Davis et al., 1999) values reported for patients at the end of being on circulatory pump support. We further evaluated the dose-dependent plasma Hb concentration data from guinea pigs to estimate the Hb elimination rate constant using a recently published biokinetic model for plasma Hb evolution in humans (Saylor et al., 2018) .
MATERIALS AND METHODS

Antibodies
Anti4-HNE (No. HNE11-S, 4-HNE, Alhpa Diagnostic, San Antonio, Texas) diluted 1: 1000 and OHdG (No. N45.1, 8-OhdG, JalCA, Japan) diluted 1:75.
PCR-Primers
Hepatitis A Virus Cellular Receptor 1 (HAVRC1 also known as Kim-1). The custom PCR primer sets for guinea pig Kim-1 (forward: 5'-GGCCCTGTCCCTCTTTCAAA -3', reverse: 5'-ACCTCGATTCGGCA ACAGTA -3'), Lipocalin-2 (forward: 5'-GTGACAGCCACCGACTA CAA -3', reverse: 5'-CTCAATTCCAGGCTCAGCTC -3') and 18S rRNA (forward: 5'-TGCATGGCCGTTCTTAGTTG -3', reverse: 5'-A GTTAGCATGCCAGAGTCTCGTT -3') were purchased from Research Central Facility for Biotechnology Resources at FDA (Silver Spring, Maryland).
Neutrophil gelatinase-associated lipocalin (Lipocalin-2 also known as NGAL). NGAL (forward: 5'-GTGACAGCCACCGACTACAA -3', reverse: 5'-CTCAATTCCAGGCTCAGCTC -3') and 18S rRNA (forward: 5'-TGCATGGCCGTTCTTAGTTG -3', reverse: 5'-AGTTA GCATGCCAGAGTCTCGTT -3') were purchased from Research Central Facility for Biotechnology Resources at FDA.
Hemoglobin
Purified human endotoxin-free Hb (Lipopolysaccharide (LPS) < 0.5 endotoxin units) was prepared from outdated blood as previously described in Irwin et al. (2015) . In brief, an additional semipreparative chromatography step was included to remove catalase via a GE Healthcare (Marlborough, Massachusetts) glass column (high-resolution 16/50; 1 1 =2 "Â 26") packed with Superose 6 (code no. 17-0489-01, Amersham Biosciences, Uppsala, Sweden). Approximately 1 g of Hb protein was loaded per run at 4 C and a flow rate of 2 ml/h. Hb protein was collected followed by buffer switching to 0.1 mM NaCl to remove catalase from the column. Several runs were pooled and concentrated to 200 mg/ ml by using Centricon Plus-70 with 30-kDa cutoff membrane filters (Millipore, Billerica, Massachusetts). The starting concentration of Hb was 250 mg/ml with composition of 96.5% 6 1.3% ferrous, 3.50% 6 0.23% ferric, and no measurable hemichrome. Metabolic cage receptacles were kept on ice and urine was removed at the end of the collection period. Volumes were recorded, urine was centrifuged at 4000 rpm for 10 min to remove any solid material, and both ferrous and ferric Hb concentrations were determined as described for plasma.
Animal and Surgical Preparation
Toxicokinetic analysis. Hb exposure parameter estimates were determined using noncompartmental methods employed by Phoenix WinNonlin version 6.4 software (Certara, Princeton, New Jersey). Maximum plasma concentrations (C max ) were determined directly from the observed data. The area under the plasma concentration time curve (AUC 0-1 ) was estimated using the linear trapezoidal rule to the last measurable concentration (AUC 0ÀC last ) where C last is the last measurable plasma concentration. Extrapolation to infinity (AUC C lastÀ1 ) was calculated by dividing C last by the negative value of the terminal slope (k) of the log-linear plasma concentration-time curve. Thus, AUC 0À1 is equal to the sum of AUC 0ÀC last and AUC C lastÀ1 . Clearance parameters were calculated as follows: the total plasma clearance (CL total ) was calculated as the Hb dose infused divided by AUC 0À1 derived from the Hb plasma concentration profile. Renal clearance (CL renal ) was calculated as the product of CL total and the fraction of Hb dose excreted in the urine (fe [urine Hb] ) over a 24-h period.
Renal Tissue Collection and Preparation
At 24 h after the start of Hb infusion, all animals were anesthetized with pentobarbital (100 mg/kg), the femoral veins were cut, and cold saline was perfused via the arterial catheter to remove blood. Kidneys were dissected, cut transversely, 1 right/ left kidney section was frozen immediately in liquid nitrogen then stored at À80 C and 1 right/left kidney section was fixed in 10% formalin for 24 h and stored in 70% isopropanol until paraffin bock embedding and sectioning.
Creatinine Measurements From Guinea Pig Plasma Creatinine concentration in plasma was measured using a creatinine assay kit purchased from Abcam (ab65340, Cambridge, Massachusetts). Plasma samples were assayed according to manufacturer's instructions. Absorbance changes were measured at 570 nm by a microplate reader (BioTek Instruments, Winooski, Vermont) and quantitative analysis was performed using a calibration curve. Each sample was tested in duplicate.
Total Iron Measurements
Kidney tissues (100 mg) were homogenized in double deionized H 2 O at 1:10 wt/vol. Homogenates were mixed with 500 ll of an acid mixture containing 1 mM HCl and 10% trichloroacetic acid, and incubated at 50 C for 1 h with intermittent shaking. The samples were then centrifuged at 15 000 Â g for 15 min at room temperature. The clear supernatant (750 ll) was mixed with 250 ll of 20 mg/ml ascorbic acid followed by 200 ll of ferrozine (0.85% wt/vol in hydroxylamine hydrochloride). The samples were developed over 30 min. The absorbance was measured at 560 nm using the Synergy 4 Hybrid Multi-Mode microplate reader (BioTek). A standard curve was generated using an iron solution standard (500 lg/dl).
Histochemical Detection of Nonheme Iron, 4-HNE and 8-OHdG
Nonheme iron histochemistry. Kidney tissue sections (5 lm) were incubated with Perls iron reagent containing 5% potassium ferrocyanide and 2% hydrochloric acid for 45 min at room temperature and rinsed in deionized water. Sections were then incubated with 0.3% hydrogen peroxide and 0.01 M sodium azide in methanol for 30 min at room temperature. All sections were then rinsed in 0.1 M phosphate buffer, pH 7.4, incubated with diaminobenzidine (SigmaFast DAB, Sigma) for 3 min, washed in deionized water, and lightly counterstained with Gill's II hematoxylin.
Immunohistochemistry. Kidney tissue sections (5 lm) were dewaxed in Safeclear II, rehydrated in graded ethanol, and heat treated in a microwave oven for 15 min in 10 mM sodium citrate buffer, pH 6.0. After cooling for 30 min at room temperature, slides were washed in phosphate-buffered saline with 0.05% Tween 20 (PBST) and incubated with Bloxall (Vector Laboratories, Burlingame, California) for 15 minutes at room temperature to inhibit endogenous peroxidases. After a brief wash, sections were blocked in 2.5% horse serum for 30 min at room temperature and then incubated overnight at 4 C with antibodies against 4-HNE (Alhpa Diagnostic, San Antonio, Texas) diluted 1:1000 or 8-OhdG (JalCA, Japan) 1:75 dilution in PBST containing 2.5% horse serum. Signal was developed using polymeric peroxidase-conjugated secondary antibodies (Vector ImmPRESS Kit) and DAB (SigmaFast DAB, Sigma). Slides were then dehydrated in graded ethanol and SafeClear, and mounted using Permount. All images were acquired using an Olympus IX71 inverted microscope.
Histopathology. The 5 lm sections were prepared from kidneys embedded in paraffin. Hematoxylin and Eosin slides were stained with alum hematoxylin, rinsed with deionized water, differentiated with 0.3% acid alcohol and stained with eosin for20Â, and severe indicates large multifocal necrosis and vacuolation with protein casts (making up > 50% of the tissue area).
Quantitative Real-Time PCR for Guinea Pig Kim-1 and NGAL Total RNA isolated from guinea pig kidney was used for cDNA synthesis. Real-time polymerase chain reactions (PCR) were performed using the Applied Biosystems ViiA 7 Real-Time PCR System and its PowerUp SYBR Green Master Mix (Applied Biosystems, Foster City, California), according to the manufacturer's protocol. The custom PCR primer sets were designed for guinea pig Kim-1 (forward: 5'-GGCCCTGTCCCTCTTTCAAA -3', reverse: 5'-ACCTCGATTCGGCAACAGTA -3'), NGAL (forward: 5'-GTGACAGCCACCGACTACAA -3', reverse: 5'-CTCAATTCCA GGCTCAGCTC -3') and 18S rRNA (forward: 5'-TGCA TGGCCGTTCTTAGTTG -3', reverse: 5'-AGTTAGCATGCCAGA GTCTCGTT -3') and purchased from the Research Central Facility for Biotechnology Resources at FDA (Silver Spring, Maryland). Real-time PCR for each gene were performed in triplicate and normalized to 18S rRNA values. Statistical analysis of real-time PCR was performed on raw DC t data.
ELISA Assay for guinea Pig Kim-1 and NGAL Kim-1 and neutrophil gelatinase-associated lipocalin (NGAL) levels in urine were measured using a guinea pig specific Kim-1 (MBS726722) or NGAL (MBS726285) enzyme-linked immunosorbent assay (ELISA) kit purchased from MyBioSource (San Diego, California). Plasma samples were diluted in sample dilution buffer and assayed according to manufacturer's instructions. Absorbance changes were measured at 450 nm by a microplate reader (BioTek Instruments) and quantitative analysis was performed by using a calibration curve, which was obtained by determining immunoactivity of each standard. Each sample was tested in duplicate.
Statistical Analysis
All data are presented as individual values (n ¼ 5 per group) with their group Mean and SDs. Significance between groups was determined based on a 1-Way ANOVA with a multiple comparisons test and a Bonferroni's correction, with significance set at p < .05. Comparisons were designed to determine difference between groups and baseline. The strength of linear associations between toxicokinetic and toxicodynamic markers was performed using Pearson product-moment Correlation and is denoted as r, significant correlations were considered at a level of r > 0.5. All statistical analyses were performed using GraphPad Prism (GraphPad Prism, version 6, La Jolla, California).
Translation of Guinea Pig to Human Plasma Hb Clearance: Biokinetic Modeling To assess the extent to which the guinea pig model may provide insight into patients subjected to elevated levels of plasma Hb, the calculated plasma Hb elimination rates were compared with those predicted by a biokinetic model that was recently developed and parameterized based on clinical data (Saylor et al., 2018) . Since guinea pigs have minimal quantities of Hp (Boretti et al., 2009) , the human biokinetic model for the evolution of total plasma mass concentration of Hb, q, as a function of time after the infusion period, t, can be simplified to:
where q 0 is the Hb concentration in plasma after cessation of infusion, q SS is the Hb concentration at steady-state, and k is a first order elimination rate constant. To evaluate the predictive capability of the animal model for humans, the guinea pig data were regressed to Equation (1) using a standard nonlinear fitting routine (LMFIT software doi: 10.5281/zenodo.11813 URL https:// lmfit.github.io/lmfit-py/; last accessed August 13, 2018), and the resulting best fit parameters compared against those obtained based on clinical data. Regression to the postinfusion data was conducted by fixing q SS ¼41.6 mg/dl, the average measured baseline value for all animals, and fitting for q 0 and k for each dosing level.
RESULTS
Toxicokinetic Assessment of 2 hours of Hb Infusion in Guinea Pigs
Plasma and urine. Following 2-h infusions of Hb at 15 mg (7.5 mg/ h), 75 mg (37.5 mg/h), 150 mg (75 mg/h), and 300 mg (150 mg/h), plasma concentrations of Hb increased rapidly and declined to basal levels over a 12-h period ( Figure 1A ). Maximum Hb plasma concentrations (C max ) increased significantly, but nonlinearly with the dose of Hb infused, from 0.13 6 0.027 g/dl after 15 mg to 0.82 6 0.11 g/dl after 300 mg ( Figure 1B) . Areas under the plasma concentration versus time curves (AUC 0Àt last ) increased in magnitude with dose; however; these exposure differences were also not linear and observed to be 1.56 6 0.374 g*h/dl after 15 mg and 4.84 6 0.461 g*h/dl after 300 mg infusions ( Figure 1C ). Following 24-h collections, the percentage of Hb excreted in urine was 31.4% 6 6.07% (data not shown). The clearance (total) of Hb was calculated as dosed Hb divided by AUC 0Àt last and increased significantly from 0.0100 6 0.00100 dl/h after 15 mg dosing to 0.0669 6 0.00419 dl/h after 150 mg dosing, however, further doses caused a plateau in clearance (total) ( Figure 1D ). Clearance (renal) of Hb, calculated as the product of clearance (total) and the fraction Hb excreted (fe) and Clearance (nonrenal) , calculated as the total-renal clearances, also increased significantly until a dose of 150 mg ( Figure 1E ).
Renal Toxicodynamic Assessment After 2 hours of Hb Infusion in Guinea Pigs
Plasma markers. Plasma or serum accumulation of creatinine is recognized as the marker of human clinical AKI. This study demonstrated an increase in group mean plasma creatinine from control (0.94 6 0.15 mg/dl) levels to (1.2 6 0.2 mg/dl) after 15 mg dosing, (1.6 6 0.17 mg/dl) after 75 mg dosing, (1.8 6 0.23 mg/dl) after 150 mg dosing, and (2.0 6 0.53 mg/dl) after 300 mg dosing ( Figure 2A ). The increase was significant following a 75-mg dose or greater with all groups demonstrating plasma creatinine levels 0.3 mg/dl greater than controls. Therefore, human clinical criteria based on Kidney Disease: Improving Global Outcomes (KDIGO) for staging of AKI placed all animals in this study with a postinfusion plasma Hb C max ! 0.26 g/dl (2.6 mg/ml) into stage 1-2 AKI, those with a plasma Hb C max between 0.13 and 0.26 g/dl (1.3-2.6 mg/ml) potentially at risk (stage 1), and those with a plasma Hb C max < 0.13 g/dl (1.3 mg/ml) not at any risk of AKI (Table 1) .
Renal mRNA markers. Renal mRNA for Kim-1 and NGAL were measured at 24 h post-Hb exposure. A significant increase in Kim-1 gene expression was observed at exposures of 15 mg Hb (9.2 6 5.7-fold), 75 mg Hb (13 6 4.2 fold), 150 mg Hb (12 6 2.5 fold) and 300 mg Hb (20 6 3.5 fold) relative to control ( Figure 2B ). However, a significant increase in NGAL mRNA was only observed after exposure to 300 mg of Hb (31 6 26-fold) relative to control ( Figure 2B ).
Renally excreted protein markers. Urinary Kim-1 and NGAL were measured at 24 h post-Hb exposure. When compared with control (90 6 19 pg/ml), Kim-1 was increased in the urine of animals exposed to 75 mg Hb (411 6 92 pg/ml) and 150 mg Hb (629 6 123 pg/ml) ( Figure 2C ). After 300 mg Hb exposure, urinary Kim-1 decreased to 218 6 11.0 pg/ml ( Figure 2C ), suggesting irreversible damage to the apical membrane of the proximal tubules and less Kim-1 protein production at the highest Hb dose evaluated (see Figure 3E ). Urinary NGAL increased significantly in animals exposed to 75, 150 and 300 mg of Hb, suggesting extrarenal production and filtration of NGAL in our study groups ( Figure 2C ). Figure 3D ). Following 300 mg Hb exposure, diffuse proximal and distal tubule cytoplasmic epithelial vacuolation and dilation with protein casts were seen ( Figure 3E ). The high magnification image of the dashed box area was indicative of hemosiderosis in proximal and distal tubules ( Figure 3F ). The external surfaces of kidneys from animals exposed to 300 mg Hb demonstrated dark patches often observed with conditions of intravascular hemolysis ( Figure 4A ). Analysis of kidney tissue demonstrated an increased quantity of iron from control animals (26 6 11 mg/100 mg) by 3-fold after 15 mg to 5-fold after 300 mg Hb exposure ( Figure 4B ). Perls-DAB staining of tissue sections shows the distribution of iron is Hb dose dependent and primarily located within the distal and proximal tubules of the renal cortex, whereas glomerular and medullary structures did not demonstrate iron accumulation ( Figure 4C ).
Iron deposition was consistent with the co-localization of the protein and DNA markers of oxidation 4-HNE and 8-OHdG, respectively. A dose dependent immune reactivity to 4-HNE adducts of renal proteins was observed as a brown staining pattern following DAB intensification in the renal cortical tubules under low (10Â) and high (60Â) magnification ( Figure 5A ). Similarly, DNA oxidation was observed following DAB intensification as increased immune reactivity to an antibody specific for 8-OHdG. Nuclear oxidation products are shown with increasing Hb dose under low (10Â) and high (100Â) magnification ( Figure 5B ). nary Kim-1 pg/ml (n ¼ 5/group) and (bottom) urinary NGAL (pg/ml). All data presented as individual values with mean 6 SD, * indicates significant differences between doses with p values shown for each comparison. All analyses were performed using a 1-way ANOVA with a multiple comparisons test and a post hoc Bonferroni's correction using GraphPad Prism, version 6, La Jolla, California. Scoring based on current KDIGO guidelines . 
Correlation of Toxicokinetic and Toxicodynamic Results
Iron deposition in tissue was the strongest toxicodynamic evidence after Hb exposure in this animal model. Renal iron demonstrated a clear correlation (Pearson's correlation coefficient, r ¼ 0.8410, p < .0001) with the maximum plasma concentration at the end of Hb exposure ( Figure 6A ). Additionally, plasma creatinine elevations correlated with Hb C max (Pearson's correlation coefficient, r ¼ 0.7283, p ¼ .0003) ( Figure 6B ). Renal Kim-1 mRNA expression relative to the Hb C max (Pearson's correlation coefficient, r ¼ 0.7425, p ¼ .0002) ( Figure 6C ), and urinary Kim-1 protein excretion relative to the Hb C max , occurred between 15 and 150 mg Hb exposures (Pearson's correlation coefficient, r ¼ 0.9470, p < .0001) ( Figure 6D ). The same toxicodynamic data were also correlated with individual AUC 0Àt last values, suggesting comparable toxicodynamic predictive capability to C max in this model (Figs. 7A-D) .
Translation of Guinea Pig to Human Hb Clearance
Plasma Hb levels after cessation of infusion in guinea pigs were all fit to the biokinetic model in Equation (1), with the best fit curves indicated by solid lines in ( Figure 8A ). To assess the range over which the model can potentially be applied, data from an additional group of guinea pigs dosed at 1000 mg Hb over 2 h were included in the analysis to demonstrate the effect of severe hemolysis. The fit values for the Hb elimination rate constant (k) are shown in (Figure 8B ), along with the standard errors. Although the uncertainty in the fit k value is quite large for low doses, the value appears to be essentially constant over the entire range of dosing levels, with best fit values between 0.20 and 0.35 1/h. These results compare quite favorably to the value determined for humans based on clinical measurements in CPB patients, where the fit value of k was found to be 0.33 6 0.3 l/h (Saylor et al., 2018) , which is also illustrated graphically in the plot ( Figure 8B ).
DISCUSSION
In this study, we hypothesized that Hb plasma levels and exposure to the kidneys occurring after a 2-h period of infusion could help define exposure limits observed following acute hemolytic events. These events may include diseases of the cardiovascular system or kidney following acute intravascular RBC lysis (Brain et al., 1962; Qian et al., 2010) as well as medical device interventions, such as CPB, short-term mechanical circulatory assist, and hemodialysis procedures. Using human classification excludes the 300 mg (150 mg/h) Hb data based on renal pathology that likely limits the protein expression of Kim-1 and its excretion in the urine. All analyses were performed with a Pearson's correlation analysis using GraphPad Prism, version 6, La Jolla, California.
guidelines for AKI, we applied data obtained from our animal model to assess the risk, injury, and failure of kidneys in Hb exposed guinea pigs. First, we defined the toxicokinetic exposure parameters (C max and AUC) occurring after increasing amounts of purified Hb were infused over a 2-hour period. Next, we related these measurements of Hb exposure to toxicodynamic biomarkers of AKI. These included the currently accepted biomarker of plasma creatinine, as well as renal mRNA expression levels and urinary protein concentrations of the novel biomarkers Kim-1 (Bonventre, 2009) and NGAL (Devarajan, 2010) . We also evaluated the role of iron deposition, protein oxidation (4-HNE) and DNA oxidation (8-OHdG) colocalization with regions of renal pathology. Finally, we fitted patient pharmacokinetic data on the elimination of plasma Hb at the end of CPB to the postinfusion data obtained in guinea pigs to demonstrate congruence between the animal and human models. The "Risk-Injury-Failure-Loss-End stage kidney disease" (RIFLE) is a consensus definition of AKI that categorizes changes in renal function based on serum/plasma creatinine and glomerular filtration rate (Ronco et al., 2015) . Additionally, the AKI Network (AKIN) has put forth a classification system of AKI (Lopes and Jorge, 2013) , and the KDIGO guidelines have suggested a combined approach to RIFLE and AKIN . Based on acute response, the KDIGO classification system suggests a baseline increase in creatinine of ! 0.3 mg/dl within 48 h as "at risk", an increase in creatinine of 2.0-2.9 times as "injury", and an increase in creatinine of 3 times baseline as "failure" (Chawla et al., 2017) . Guinea pigs in this study demonstrated normal group mean plasma creatinine levels at baseline (0.94 mg/d). After Hb exposure, plasma creatinine began to increase to a maximum of 2.0 mg/dl after 300 mg Hb dosing. Data from this study suggest that animals exposed to >15 mg Hb could either be at risk for, or experience, AKI. This observation is limited to normal animals absent concomitant pathophysiology. Therefore, AKI may occur at substantially lower Hb exposures in disease state compromised animals and patients. The results obtained here following Hb exposures suggest that the model presented herein represents an excellent predictor of AKI in otherwise normal animals.Both toxicokinetic parameters (plasma Hb C max and AUC) significantly correlated with toxicodynamic responses to plasma creatinine and experimental markers of AKI, including Kim-1 renal mRNA expression and Kim-1 excretion in the urine. NGAL mRNA and urinary NGAL were also consistently elevated following Hb exposures, but with greater variability. The observation that C max effectively predicted injury suggests that a single concentration at the end of Hb infusion could be used in lieu of a multiple sampling approach, required for AUC calculations. C max also correlated with renal iron deposition, which colocalized with 4-HNE protein adducts, and 8-OhdG DNA oxidation within the renal cortex distal and proximal tubules. When these results are coupled with observations of pathological vacuolation in the same regions of the renal cortex, our data suggest that Hb mediated prooxidative processes following compartmentalization in the kidney are relevant and important toxicological mechanisms following Hb exposures. To expand on the translational aspects of the guinea pig model to humans, we used the post-infusion plasma Hb concentrations from each animal dosing group to fit for the Hb elimination rate constant using a recently published biokinetic model for plasma Hb evolution in humans (Saylor et al., 2018) . Based on human pharmacokinetic data from clinical literature (see Saylor et al., 2018) , the plasma Hb elimination rate constant estimated for humans immediately after CPB procedures was similar to the Hb elimination rate constant calculated in our guinea pig model. We found that these estimated Hb elimination rate constants were largely independent of Hb dose over a very wide range (15-1000 mg) of Hb. This not only suggests that the guinea pig model can be used to inform about human responses to Hb, but also supports one of the assumptions underpinning the biokinetic model, namely that the Hb elimination rate constant (kÞ is independent of Hb concentration. Although baseline guinea pig plasma Hb levels were somewhat elevated, most likely due to some collection-induced hemolysis by the use of small-bore blood sampling catheters, Equation (1) reveals that it remains invariant for constant q t ð Þ À q SS . Thus, any sampling artifacts such as collection-induced hemolysis will not impact the fit k values. We note that comparable levels of Hb where observed at baseline prior to infusion and at steady-state 12-h postinfusion. These plasma Hb levels (20-70 mg/dl) are consistent with blood collection related hemolysis reported at baseline in adult (Cheung et al., 2007) and pediatric patients (Mamikonian et al., 2014) in studies evaluating Hb-and CPB-related adverse events. The observed consistency between the guinea pig and human Hb elimination rate constants suggests that the model is adequately capturing the primary mechanisms of Hb introduction and removal from plasma in the animals. Although our results propose that guinea pigs can provide significant insight into the biokinetics of Hb in humans, the animal model has its limitations. For example, guinea pigs have very low concentrations of plasma Hp, which can bind and safely remove plasma Hb in humans. Thus, the animal model cannot provide information on the rate of elimination and generation of plasma Hp or Hb-Hp complexes. Overall, our study suggests that C max of plasma Hb may effectively predict the risk of AKI in normal healthy animals, and that the pharmacokinetic response to Hb exposure in guinea pigs is similar to humans after CPB.
